Diabetes mellitus Type 2
Conditions
Interventions
Group 1: A routine laboratory sample is taken during the inpatient stay for the surgical procedure. The data from this laboratory will also be used for the study. A continuous glucose monitoring syste
Sponsors
Medizinische Univeristät Graz
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria (patients undergoing pancreas surgery): - Admitted to hospital for visceral surgery - Age 18-80 years (both inclusive) - Written informed consent Inclusion criteria (patients undergoing other abdominal surgery): - People with type 2 diabetes either on dietary control or on glucose lowering treatment including any oral glucose lowering drugs or GLP1-receptor agonists - Admitted to hospital for major visceral surgery (hepatobiliary, colorectal, gastric) - Age 18-80 years (both inclusive) - Written informed consent
Exclusion criteria
Exclusion criteria: Exclusion criteria (for all patients): • Type 1 diabetes • Pre-existing insulin treatment • Insulin pump treatment • Glucocorticoid treatment • Endstage renal disease (CKD G5) • Severe liver impairment (Child C) • Any mental condition rendering the patient incapable of giving informed consent • Participation in another trial which might interfere with the procedures of this trial • Duration of hospital stay less than 5 days
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Association of TIR (Time in Range) with the incidence and severity of post-surgery complications (Grade II-V on Clavien-Dindo Classification). | — |
Secondary
| Measure | Time frame |
|---|---|
| - Association of TIR categories to Grade II complications (Clavien-Dindo Classification) - Association of TIR categories to Grade III complications (Clavien-Dindo Classification) - Association of TIR categories Grade IV complications (Clavien-Dindo Classification) - Composite of postsurgical complications during the index hospital stay only - Length of hospital stay - Length of ICU stay - 180-day mortality - Acute kidney injuries - Number of re-hospitalisations after discharge - Glyaemic parameters including TIR, TTR, TARI, TBR1, TAR2, TBR, Mean glucose and glucose variability | — |
Countries
Austria
Contacts
Public ContactHarald Sourij
Medizinische Univeristät Graz
Outcome results
None listed